Company Univo Pharmaceuticals Ltd TEL AVIV STOCK EXCHANGE
Equities
UNVO
IL0010935588
Biotechnology & Medical Research
Business Summary
Sales per Business
ILS in Million | 2020 | Weight | 2021 | Weight | Delta |
---|---|---|---|---|---|
Medical Cannabis
89.4
%
| 19 | 57.3 % | 38 | 89.4 % | +95.57% |
Cannabis Product Manufacturing Services
7.7
%
| 5 | 15.0 % | 3 | 7.7 % | -35.48% |
Marketing and Distribution Commissions
2.1
%
| 1 | 2.5 % | 1 | 2.1 % | +5.04% |
Laboratory Services
0.6
%
| 8 | 25.1 % | 0 | 0.6 % | -96.79% |
Other Income
0.1
%
| - | - | 0 | 0.1 % | - |
Sales per region
ILS in Million | 2020 | Weight | 2021 | Weight | Delta |
---|---|---|---|---|---|
Israel
100.0
%
| 34 | 100.0 % | 42 | 100.0 % | +25.38% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Golan Bitton
CEO | Chief Executive Officer | 48 | 04/93/04 |
Jonathan Eilat
IRC | Investor Relations Contact | - | - |
Noam Frakash
AUD | Comptroller/Controller/Auditor | 41 | 01/22/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chaim Hurvitz
CHM | Chairman | 63 | 15/19/15 |
Golan Bitton
CEO | Chief Executive Officer | 48 | 04/93/04 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 3,293 | 1,952 ( 59.28 %) | 0 | 59.28 % |
Company contact information
Univo Pharmaceuticals Ltd.
20 HaHarash Street
7878320, Ashkelon
+
Sector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
+0.67% | 42.19B | |
+44.30% | 40.15B | |
-6.20% | 28.31B | |
+6.55% | 24.63B | |
-21.66% | 18.2B | |
+29.96% | 12.01B | |
-1.57% | 11.76B | |
+16.03% | 10.4B | |
-4.80% | 9.94B |